Show
Sort by
-
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Chrildren's Leukemia Group study 58951
-
Minimal residual disease quantification by PCR in childhood acute lymphoblastic leukaemia
-
Impact of minimal residual disease monitoring on therapy in Belgian childhood acute lymphoblastic leukaemia
-
An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions
-
Guidelines for an integrated diagnostic approach of chronic lymphoproliferative diseases in the routine laboratory of haematology in Belgium
-
Minimal residual disease detection at day 35 in childhood acute lymphoblastic leukemia: Which technique(s) to use?
-
Which technique(s) to use when studying minimal residual disease at day 35 in childhood acute lymphoblastic leukemia: a multicenter approach.
-
Which technique(s) to use when studying minimal residual disease at day 35 in childhood acute lymphoblastic leukemia: a multicenter approach.